This project aims at the development of nanoparticles that are selectively recognized and taken up by tumor associated macrophages (TAMs). This phenotype of macrophages is known for its pro-tumoral activity. Therefore we will engineer nanoparticles to reprogram TAMs into an anti-tumoral phenotype to allow fora n improved anti-cancer treatment.